Literature DB >> 2273212

Hypothyroidism and goiter during interleukin-2 therapy.

P Berthaud, M Schlumberger, E Comoy, M F Avril, T Le Chevalier, M Spielmann, T Tursz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2273212     DOI： 10.1007/BF03349600

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  4 in total

1.  Hypothyroidism and goitre during interleukin-2 therapy without LAK cells.

Authors:  P A van Liessum; P H de Mulder; E J Mattijssen; F H Corstens; D J Wagener
Journal:  Lancet       Date:  1989-01-28       Impact factor: 79.321

2.  Immunoregulation in autoimmune thyroid disease.

Authors:  R Volpé
Journal:  N Engl J Med       Date:  1987-01-01       Impact factor: 91.245

3.  Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity.

Authors:  G F Bottazzo; R Pujol-Borrell; T Hanafusa; M Feldmann
Journal:  Lancet       Date:  1983-11-12       Impact factor: 79.321

4.  Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells.

Authors:  M B Atkins; J W Mier; D R Parkinson; J A Gould; E M Berkman; M M Kaplan
Journal:  N Engl J Med       Date:  1988-06-16       Impact factor: 91.245
  4 in total
  2 in total

Review 1.  Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer.

Authors:  Ruth Whittington; Diana Faulds
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

Review 2.  Clinical toxicity of interleukin-2.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.